{"id": "article-25879_0", "title": "Nicotine Addiction -- Continuing Education Activity", "content": "Nicotine addiction is a complex disorder with no easy cure. Habitual use of tobacco and tobacco products continues to be a significant contributor to health problems worldwide, which in part may be related to the increasing affordability of tobacco and nicotine products as well as marketing strategies that increasingly utilize social media to reach consumers. This activity reviews the evaluation and management of nicotine addiction and the role of the interprofessional team in caring for affected patients.", "contents": "Nicotine Addiction -- Continuing Education Activity. Nicotine addiction is a complex disorder with no easy cure. Habitual use of tobacco and tobacco products continues to be a significant contributor to health problems worldwide, which in part may be related to the increasing affordability of tobacco and nicotine products as well as marketing strategies that increasingly utilize social media to reach consumers. This activity reviews the evaluation and management of nicotine addiction and the role of the interprofessional team in caring for affected patients."}
{"id": "article-25879_1", "title": "Nicotine Addiction -- Continuing Education Activity", "content": "Objectives: Describe the typical clinical presentation of a patient with nicotine addiction. Describe the etiologic factors associated with the development of nicotine addiction. Review management strategies for nicotine addiction. Explain the importance of enhancing care coordination amongst the interprofessional team to improve outcomes for patients with nicotine addiction. Access free multiple choice questions on this topic.", "contents": "Nicotine Addiction -- Continuing Education Activity. Objectives: Describe the typical clinical presentation of a patient with nicotine addiction. Describe the etiologic factors associated with the development of nicotine addiction. Review management strategies for nicotine addiction. Explain the importance of enhancing care coordination amongst the interprofessional team to improve outcomes for patients with nicotine addiction. Access free multiple choice questions on this topic."}
{"id": "article-25879_2", "title": "Nicotine Addiction -- Introduction", "content": "The habitual use of tobacco and tobacco products continues to be a significant contributor\u00a0to health problems worldwide. The increasing affordability of tobacco and nicotine products has been a contributing factor as well as marketing strategies\u00a0that increasingly use social media to reach consumers globally. Smoking and chewing tobacco remain the main source of nicotine exposure in humans. Nicotine addiction remains one of the easiest addictions to fall into, can develop rapidly and one of the toughest addictions to get rid of. Once addicted, people take tobacco products to deliver the desired dose of nicotine as body demands and there is individual variation regarding the intervals between the dose and the rate of delivery. It is associated with significant morbidity and mortality worldwide. So nicotine addiction is a subject of great public health concern. [1] [2] [3]", "contents": "Nicotine Addiction -- Introduction. The habitual use of tobacco and tobacco products continues to be a significant contributor\u00a0to health problems worldwide. The increasing affordability of tobacco and nicotine products has been a contributing factor as well as marketing strategies\u00a0that increasingly use social media to reach consumers globally. Smoking and chewing tobacco remain the main source of nicotine exposure in humans. Nicotine addiction remains one of the easiest addictions to fall into, can develop rapidly and one of the toughest addictions to get rid of. Once addicted, people take tobacco products to deliver the desired dose of nicotine as body demands and there is individual variation regarding the intervals between the dose and the rate of delivery. It is associated with significant morbidity and mortality worldwide. So nicotine addiction is a subject of great public health concern. [1] [2] [3]"}
{"id": "article-25879_3", "title": "Nicotine Addiction -- Etiology", "content": "Nicotine is a plant alkaloid, found in the tobacco plant. The main source of nicotine is tobacco. Two major sources of nicotine are Large leaf tobacco plants( Nicotiana tabacum ) and small leaf tobacco plants ( Nicotiana rustica ). The main means of administration are smoking pipes/cigars, chewing, and also snorting fine powders. It is also being used as a pharmacological means of cessation of smoke.\u00a0Tobacco control has been a priority of almost every county in the world.\u00a0 There are many alternate nicotine preparations like nicotine patches, nicotine gums, e-cigarettes, and inhalational agents available. These products have been promoted and marketed as exceptional alternatives and remedies. Major causes of nicotine addiction include lack of enforcement of smoking bans, lack of proper knowledge and education on the topic (mostly in underdeveloped countries), lack of motivation to quit smoking, inadequate training among mental health professionals, and inadequate treatments. [4]", "contents": "Nicotine Addiction -- Etiology. Nicotine is a plant alkaloid, found in the tobacco plant. The main source of nicotine is tobacco. Two major sources of nicotine are Large leaf tobacco plants( Nicotiana tabacum ) and small leaf tobacco plants ( Nicotiana rustica ). The main means of administration are smoking pipes/cigars, chewing, and also snorting fine powders. It is also being used as a pharmacological means of cessation of smoke.\u00a0Tobacco control has been a priority of almost every county in the world.\u00a0 There are many alternate nicotine preparations like nicotine patches, nicotine gums, e-cigarettes, and inhalational agents available. These products have been promoted and marketed as exceptional alternatives and remedies. Major causes of nicotine addiction include lack of enforcement of smoking bans, lack of proper knowledge and education on the topic (mostly in underdeveloped countries), lack of motivation to quit smoking, inadequate training among mental health professionals, and inadequate treatments. [4]"}
{"id": "article-25879_4", "title": "Nicotine Addiction -- Epidemiology", "content": "The prevalence of nicotine addiction can be directly estimated from tobacco consumption which is interlinked. World Health Organization estimates that there are around 1.27 billion tobacco users in the world.\u00a0In 2017, the Center for Disease Control estimates that 19.3% of the US population over 18 years old use some kind of tobacco products. About 14% of the population use cigarettes and the remaining 5% use cigars, smokeless tobacco or pipes, and\u00a0electronic cigarettes. Around 24.8% of men and around 14.2% of women smoke cigarettes. According to the age group, the smoker population represent 18.3% of adults aged 18-24 years old, 22.5% of adults aged 25-44 years old, 21.3% of adults aged 45-64 years old, and 11% of adults 65 and older.\u00a0At present, newer products like nicotine gums, patches, e-cigarettes, and inhalational agents constitute around 1% of total nicotine consumption worldwide and are showing a growing trend in most countries.", "contents": "Nicotine Addiction -- Epidemiology. The prevalence of nicotine addiction can be directly estimated from tobacco consumption which is interlinked. World Health Organization estimates that there are around 1.27 billion tobacco users in the world.\u00a0In 2017, the Center for Disease Control estimates that 19.3% of the US population over 18 years old use some kind of tobacco products. About 14% of the population use cigarettes and the remaining 5% use cigars, smokeless tobacco or pipes, and\u00a0electronic cigarettes. Around 24.8% of men and around 14.2% of women smoke cigarettes. According to the age group, the smoker population represent 18.3% of adults aged 18-24 years old, 22.5% of adults aged 25-44 years old, 21.3% of adults aged 45-64 years old, and 11% of adults 65 and older.\u00a0At present, newer products like nicotine gums, patches, e-cigarettes, and inhalational agents constitute around 1% of total nicotine consumption worldwide and are showing a growing trend in most countries."}
{"id": "article-25879_5", "title": "Nicotine Addiction -- Epidemiology", "content": "Tobacco use accounts for more than 5 million deaths worldwide each\u00a0year. On average, around 435,000 people in the United States(US) suffer death prematurely from smoking-related diseases each year. Overall, smoking causes 1 out of 5 deaths. There is a 50% chance that a lifelong smoker will probably die prematurely from complications of smoking. The deaths due to tobacco consumption are reported to be twice the number of deaths due to alcohol and narcotic drugs combined. Most of the deaths due to tobacco use occur in low or middle-income countries. Cigarette smoking is a leading cause of preventable diseases and premature deaths in the United States along with other countries. [5] [6] [7] [8] [9]", "contents": "Nicotine Addiction -- Epidemiology. Tobacco use accounts for more than 5 million deaths worldwide each\u00a0year. On average, around 435,000 people in the United States(US) suffer death prematurely from smoking-related diseases each year. Overall, smoking causes 1 out of 5 deaths. There is a 50% chance that a lifelong smoker will probably die prematurely from complications of smoking. The deaths due to tobacco consumption are reported to be twice the number of deaths due to alcohol and narcotic drugs combined. Most of the deaths due to tobacco use occur in low or middle-income countries. Cigarette smoking is a leading cause of preventable diseases and premature deaths in the United States along with other countries. [5] [6] [7] [8] [9]"}
{"id": "article-25879_6", "title": "Nicotine Addiction -- Pathophysiology", "content": "Nicotine is an amine found in tobacco and tobacco products. It is the addictive agent which confers a much lower risk than other elements of tobacco,\u00a0but it is not completely\u00a0benign. When tobacco smoke is inhaled, nicotine\u00a0rapidly enters the bloodstream through the pulmonary circulation. Inhaled nicotine escapes the first pass intestinal and liver metabolism. Nicotine readily crosses the blood-brain\u00a0barrier which then promptly\u00a0diffuses into the brain tissue. The process is said to take only 2 to 8 seconds from the time of inhalation. Nicotine is a selective binder to nicotinic cholinergic\u00a0receptors (nAChRs) in the brain and other tissues. The half-life\u00a0of nicotine in the human body is estimated to be around 2 hours from the time of consumption.", "contents": "Nicotine Addiction -- Pathophysiology. Nicotine is an amine found in tobacco and tobacco products. It is the addictive agent which confers a much lower risk than other elements of tobacco,\u00a0but it is not completely\u00a0benign. When tobacco smoke is inhaled, nicotine\u00a0rapidly enters the bloodstream through the pulmonary circulation. Inhaled nicotine escapes the first pass intestinal and liver metabolism. Nicotine readily crosses the blood-brain\u00a0barrier which then promptly\u00a0diffuses into the brain tissue. The process is said to take only 2 to 8 seconds from the time of inhalation. Nicotine is a selective binder to nicotinic cholinergic\u00a0receptors (nAChRs) in the brain and other tissues. The half-life\u00a0of nicotine in the human body is estimated to be around 2 hours from the time of consumption."}
{"id": "article-25879_7", "title": "Nicotine Addiction -- Pathophysiology", "content": "Brain imaging studies have demonstrated that nicotine acutely increases activity in the prefrontal cortex, thalamus, and visual system consistent with activation of corticobasal ganglia and thalamic brain circuits. Nicotine which stimulates nAChRs produces the release of neurotransmitters, predominantly\u00a0dopamine but also norepinephrine, acetylcholine, serotonin, GABA, glutamate, and endorphins. These\u00a0neurotransmitters\u00a0cause\u00a0the various responses and behaviors after nicotine intake. When there is repeated exposure to nicotine, tolerance develops to some of the physiological effects of nicotine.\u00a0Nicotine is a sympathomimetic\u00a0drug that causes the release of catecholamines and increases heart rate, cardiac contractility, constricts cutaneous and coronary blood vessels and increases blood pressure.", "contents": "Nicotine Addiction -- Pathophysiology. Brain imaging studies have demonstrated that nicotine acutely increases activity in the prefrontal cortex, thalamus, and visual system consistent with activation of corticobasal ganglia and thalamic brain circuits. Nicotine which stimulates nAChRs produces the release of neurotransmitters, predominantly\u00a0dopamine but also norepinephrine, acetylcholine, serotonin, GABA, glutamate, and endorphins. These\u00a0neurotransmitters\u00a0cause\u00a0the various responses and behaviors after nicotine intake. When there is repeated exposure to nicotine, tolerance develops to some of the physiological effects of nicotine.\u00a0Nicotine is a sympathomimetic\u00a0drug that causes the release of catecholamines and increases heart rate, cardiac contractility, constricts cutaneous and coronary blood vessels and increases blood pressure."}
{"id": "article-25879_8", "title": "Nicotine Addiction -- Pathophysiology", "content": "Nicotine undergoes metabolism in the liver, primarily by the liver enzyme CYP2A6, and converts nicotine to cotinine. Cotinine is a metabolite that can be used as\u00a0a marker for exposure to nicotine. There are broad individual and racial variations in the rate of nicotine metabolism due to genetic polymorphism in CYP2A6. Thus the metabolism of nicotine is faster in Caucasians\u00a0than Asians and Africans.\u00a0Sex hormones also significantly affect CYP2A6 activity,\u00a0and females metabolize nicotine faster than males. [10] [11]", "contents": "Nicotine Addiction -- Pathophysiology. Nicotine undergoes metabolism in the liver, primarily by the liver enzyme CYP2A6, and converts nicotine to cotinine. Cotinine is a metabolite that can be used as\u00a0a marker for exposure to nicotine. There are broad individual and racial variations in the rate of nicotine metabolism due to genetic polymorphism in CYP2A6. Thus the metabolism of nicotine is faster in Caucasians\u00a0than Asians and Africans.\u00a0Sex hormones also significantly affect CYP2A6 activity,\u00a0and females metabolize nicotine faster than males. [10] [11]"}
{"id": "article-25879_9", "title": "Nicotine Addiction -- Histopathology", "content": "In animals, nicotine can inhibit\u00a0apoptosis, resulting in the impaired killing of malignant cells. Nicotine\u00a0also has\u00a0promoted angiogenesis in animals, which could lead to more significant tumor invasion and metastases.", "contents": "Nicotine Addiction -- Histopathology. In animals, nicotine can inhibit\u00a0apoptosis, resulting in the impaired killing of malignant cells. Nicotine\u00a0also has\u00a0promoted angiogenesis in animals, which could lead to more significant tumor invasion and metastases."}
{"id": "article-25879_10", "title": "Nicotine Addiction -- Toxicokinetics", "content": "Animal studies have found nicotine exposure to increase behavioral control of conditioned stimuli, which may contribute to the compulsive smoking behavior. Although conditioning is an important element of nicotine addiction, conditioning primarily develops because of the pharmacological actions of the drug with behaviors.", "contents": "Nicotine Addiction -- Toxicokinetics. Animal studies have found nicotine exposure to increase behavioral control of conditioned stimuli, which may contribute to the compulsive smoking behavior. Although conditioning is an important element of nicotine addiction, conditioning primarily develops because of the pharmacological actions of the drug with behaviors."}
{"id": "article-25879_11", "title": "Nicotine Addiction -- History and Physical", "content": "Intake\u00a0of nicotine from tobacco smoke or products produces stimulation and a decrease in a feeling of stress and anxiety. Thus smokers modulate their consumption to experience arousal and mood control day. Smoking may improve concentration, reaction time, and performance in specific areas. But when there is a cessation of smoking, there is the appearance\u00a0of nicotine withdrawal symptoms. Withdrawal symptoms\u00a0may manifest as irritability, mood depression, anxiety, inability to socialize, increased appetite\u00a0or desire to eat, and sleeplessness. If nicotine withdrawal\u00a0is left untreated in habitual tobacco users, it may produce symptoms with similar intensity as psychiatric\u00a0disorders.", "contents": "Nicotine Addiction -- History and Physical. Intake\u00a0of nicotine from tobacco smoke or products produces stimulation and a decrease in a feeling of stress and anxiety. Thus smokers modulate their consumption to experience arousal and mood control day. Smoking may improve concentration, reaction time, and performance in specific areas. But when there is a cessation of smoking, there is the appearance\u00a0of nicotine withdrawal symptoms. Withdrawal symptoms\u00a0may manifest as irritability, mood depression, anxiety, inability to socialize, increased appetite\u00a0or desire to eat, and sleeplessness. If nicotine withdrawal\u00a0is left untreated in habitual tobacco users, it may produce symptoms with similar intensity as psychiatric\u00a0disorders."}
{"id": "article-25879_12", "title": "Nicotine Addiction -- History and Physical", "content": "The relative decrease in dopamine release\u00a0following longstanding nicotine exposure is a possible explanation for many of the mood disturbances as well as tobacco craving experienced by smokers for a long time even after they have stopped smoking. The habituation to cigarette smoking is partly maintained because of conditioning. People habitually smoke cigarettes in specific situations such as after a meal, with a cup of coffee or an alcoholic drink, or in the company of friends who smoke.", "contents": "Nicotine Addiction -- History and Physical. The relative decrease in dopamine release\u00a0following longstanding nicotine exposure is a possible explanation for many of the mood disturbances as well as tobacco craving experienced by smokers for a long time even after they have stopped smoking. The habituation to cigarette smoking is partly maintained because of conditioning. People habitually smoke cigarettes in specific situations such as after a meal, with a cup of coffee or an alcoholic drink, or in the company of friends who smoke."}
{"id": "article-25879_13", "title": "Nicotine Addiction -- Evaluation", "content": "Nicotine is metabolized to cotinine and then to trans-3'-hydroxycotinine\u00a0or nornicotine\u00a0and other chemicals such as anabasine. Both of these metabolites can be detected in urine and blood. With a long half-life\u00a0of 16 hours. These tests can be used to test compliance with\u00a0withdrawal therapy or nicotine toxicity. Another method\u00a0to assess nicotine is COa level. This method is related to cotinine. Some questionnaires can measure nicotine dependence such as the Fagerstrom Test for Nicotine Dependence, Wisconsin Inventory of Smoking Dependence and Motives, and Smokeless Tobacco Dependence Scale. [12] [13] [14]", "contents": "Nicotine Addiction -- Evaluation. Nicotine is metabolized to cotinine and then to trans-3'-hydroxycotinine\u00a0or nornicotine\u00a0and other chemicals such as anabasine. Both of these metabolites can be detected in urine and blood. With a long half-life\u00a0of 16 hours. These tests can be used to test compliance with\u00a0withdrawal therapy or nicotine toxicity. Another method\u00a0to assess nicotine is COa level. This method is related to cotinine. Some questionnaires can measure nicotine dependence such as the Fagerstrom Test for Nicotine Dependence, Wisconsin Inventory of Smoking Dependence and Motives, and Smokeless Tobacco Dependence Scale. [12] [13] [14]"}
{"id": "article-25879_14", "title": "Nicotine Addiction -- Treatment / Management", "content": "The three types of medication are used for smoking cessation are\u00a0as follows:", "contents": "Nicotine Addiction -- Treatment / Management. The three types of medication are used for smoking cessation are\u00a0as follows:"}
{"id": "article-25879_15", "title": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Products", "content": "These include products such skin patches or gum. Often nicotine replacement products are not used correctly. It has been recommended that the bite and park technique is used rather than chewing the gum. [2] [6] [15]", "contents": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Products. These include products such skin patches or gum. Often nicotine replacement products are not used correctly. It has been recommended that the bite and park technique is used rather than chewing the gum. [2] [6] [15]"}
{"id": "article-25879_16", "title": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications", "content": "Bupropion and, most recently, varenicline\u00a0has been shown to be effective for smoking cessation. Nortriptyline and Clonidine are considered as the second-line drugs. Nicotine replacement medications are believed to facilitate smoking cessation in several ways: (1) Their primary action is by the relief\u00a0of withdrawal symptoms when a person stops tobacco use. (2) The second mechanism of benefit is positive reinforcement particularly for the arousal and stress-relieving effect. (3) The third\u00a0possible mechanism of benefit is related to the ability of nicotine medication to desensitize nicotine receptors. Bupropion: initially marketed as an antidepressant; increases brain levels of dopamine and norepinephrine, simulating the effect of nicotine on these neurotransmitters. Varenicline: an analog\u00a0of cysteine, a naturally\u00a0occurring plant alkaloid; has a strong binding affinity for nAChR.", "contents": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications. Bupropion and, most recently, varenicline\u00a0has been shown to be effective for smoking cessation. Nortriptyline and Clonidine are considered as the second-line drugs. Nicotine replacement medications are believed to facilitate smoking cessation in several ways: (1) Their primary action is by the relief\u00a0of withdrawal symptoms when a person stops tobacco use. (2) The second mechanism of benefit is positive reinforcement particularly for the arousal and stress-relieving effect. (3) The third\u00a0possible mechanism of benefit is related to the ability of nicotine medication to desensitize nicotine receptors. Bupropion: initially marketed as an antidepressant; increases brain levels of dopamine and norepinephrine, simulating the effect of nicotine on these neurotransmitters. Varenicline: an analog\u00a0of cysteine, a naturally\u00a0occurring plant alkaloid; has a strong binding affinity for nAChR."}
{"id": "article-25879_17", "title": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications", "content": "Rimonabant: a cannabinoid receptor antagonist which is effective as an aid for smoking cessation.It is believed to contribute to reinforcing effects of nicotine action. Two other medications of interest: Mecamylamine: a noncompetitive antagonist\u00a0of nicotinic cholinergic\u00a0receptors;\u00a0blocks nicotinic effect as well as reinforcement lobeline: an alkaloid which is a nicotine receptor agonist;\u00a0satisfies\u00a0the nicotine receptor. Phase 1 and phase 2 clinical trials are studying the effect of a nicotine vaccine that produces\u00a0antibodies that bind to nicotine to prevent it from acting on nicotine receptors.", "contents": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications. Rimonabant: a cannabinoid receptor antagonist which is effective as an aid for smoking cessation.It is believed to contribute to reinforcing effects of nicotine action. Two other medications of interest: Mecamylamine: a noncompetitive antagonist\u00a0of nicotinic cholinergic\u00a0receptors;\u00a0blocks nicotinic effect as well as reinforcement lobeline: an alkaloid which is a nicotine receptor agonist;\u00a0satisfies\u00a0the nicotine receptor. Phase 1 and phase 2 clinical trials are studying the effect of a nicotine vaccine that produces\u00a0antibodies that bind to nicotine to prevent it from acting on nicotine receptors."}
{"id": "article-25879_18", "title": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications", "content": "Genome-wide\u00a0association studies that are exploring the possibility of using gene clusters such as the CHNRA5 and CYP2A6 genes that are involved with nicotine metabolism and its conversion continue as a surrogate marker for response to therapy of nicotine replacement.", "contents": "Nicotine Addiction -- Treatment / Management -- Nicotine Replacement Medications. Genome-wide\u00a0association studies that are exploring the possibility of using gene clusters such as the CHNRA5 and CYP2A6 genes that are involved with nicotine metabolism and its conversion continue as a surrogate marker for response to therapy of nicotine replacement."}
{"id": "article-25879_19", "title": "Nicotine Addiction -- Differential Diagnosis", "content": "Alpha 1-Antitrypsin (AAT) deficiency Angina pectoris Chronic obstructive pulmonary disease(COPD) Depression Emphysema Histiocytosis X Idiopathic pneumothorax Low birth weight Non-small cell lung cancer Obstructive sleep apnea Respiratory bronchitis Small cell lung cancer", "contents": "Nicotine Addiction -- Differential Diagnosis. Alpha 1-Antitrypsin (AAT) deficiency Angina pectoris Chronic obstructive pulmonary disease(COPD) Depression Emphysema Histiocytosis X Idiopathic pneumothorax Low birth weight Non-small cell lung cancer Obstructive sleep apnea Respiratory bronchitis Small cell lung cancer"}
{"id": "article-25879_20", "title": "Nicotine Addiction -- Prognosis", "content": "The adverse reproductive effects of nicotine are predominantly fetal neuroteratogenic\u00a0effect. Smoking has been associated with retardation of fetal growth. Evidence shows that smoking is causative for premature births, stillbirths,\u00a0placental abruption, and sudden infant death syndrome. The incidence of spontaneous abortions, ectopic pregnancies, and placenta previa in women smokers is increasing. Behavioral disorders have been observed among infants born to mothers who smoke during pregnancy. Smoking is recognized as a significant risk factor for poor maternal-fetal\u00a0outcomes.", "contents": "Nicotine Addiction -- Prognosis. The adverse reproductive effects of nicotine are predominantly fetal neuroteratogenic\u00a0effect. Smoking has been associated with retardation of fetal growth. Evidence shows that smoking is causative for premature births, stillbirths,\u00a0placental abruption, and sudden infant death syndrome. The incidence of spontaneous abortions, ectopic pregnancies, and placenta previa in women smokers is increasing. Behavioral disorders have been observed among infants born to mothers who smoke during pregnancy. Smoking is recognized as a significant risk factor for poor maternal-fetal\u00a0outcomes."}
{"id": "article-25879_21", "title": "Nicotine Addiction -- Complications", "content": "Lung cancer Peripheral vascular disease Bronchitis COPD/Emphysema Halitosis Head and neck cancer Stained teeth", "contents": "Nicotine Addiction -- Complications. Lung cancer Peripheral vascular disease Bronchitis COPD/Emphysema Halitosis Head and neck cancer Stained teeth"}
{"id": "article-25879_22", "title": "Nicotine Addiction -- Deterrence and Patient Education", "content": "Clinicians have an opportunity to\u00a0impact treatment\u00a0outcomes significantly\u00a0by incorporating patient education on the critical issues of nicotine addiction. Individualized psychosocial\u00a0or community-based interventions can help to reduce the use of medications.", "contents": "Nicotine Addiction -- Deterrence and Patient Education. Clinicians have an opportunity to\u00a0impact treatment\u00a0outcomes significantly\u00a0by incorporating patient education on the critical issues of nicotine addiction. Individualized psychosocial\u00a0or community-based interventions can help to reduce the use of medications."}
{"id": "article-25879_23", "title": "Nicotine Addiction -- Pearls and Other Issues", "content": "Substantial evidence supports combining both psychosocial and pharmacological interventions for the best results.The best outcomes are when medications are combined with behavioral therapy and community-based interventions.", "contents": "Nicotine Addiction -- Pearls and Other Issues. Substantial evidence supports combining both psychosocial and pharmacological interventions for the best results.The best outcomes are when medications are combined with behavioral therapy and community-based interventions."}
{"id": "article-25879_24", "title": "Nicotine Addiction -- Enhancing Healthcare Team Outcomes", "content": "Nicotine addiction is a complex disorder with no easy cure. Millions of people throughout the globe would like to discontinue smoking but cannot. Many people try to quit smoking and are successful for a few weeks or months but relapse rates are very\u00a0high. There is no one magical treatment to curing nicotine addiction but evidence suggests that an interprofessional approach that encourages changes in lifestyle may have better outcomes. The nurse is in the prime position to educate the patient at discharge. The pharmacist can educate outpatients on the adverse effects of smoking. The social worker should encourage the patient to change lifestyle, join a support group and keep away from people who smoke. The pharmacist may recommend nicotine substitutes but at the same time\u00a0should encourage a healthy diet, starting a new hobby and participating in an exercise program.\u00a0 Some individuals may benefit from cognitive behavior therapy. Finally physicians should continually enforce the importance of nicotine cessation and remind the patient that\u00a0it adversely affects health. [16] [17] [18] [Level 5]", "contents": "Nicotine Addiction -- Enhancing Healthcare Team Outcomes. Nicotine addiction is a complex disorder with no easy cure. Millions of people throughout the globe would like to discontinue smoking but cannot. Many people try to quit smoking and are successful for a few weeks or months but relapse rates are very\u00a0high. There is no one magical treatment to curing nicotine addiction but evidence suggests that an interprofessional approach that encourages changes in lifestyle may have better outcomes. The nurse is in the prime position to educate the patient at discharge. The pharmacist can educate outpatients on the adverse effects of smoking. The social worker should encourage the patient to change lifestyle, join a support group and keep away from people who smoke. The pharmacist may recommend nicotine substitutes but at the same time\u00a0should encourage a healthy diet, starting a new hobby and participating in an exercise program.\u00a0 Some individuals may benefit from cognitive behavior therapy. Finally physicians should continually enforce the importance of nicotine cessation and remind the patient that\u00a0it adversely affects health. [16] [17] [18] [Level 5]"}
{"id": "article-25879_25", "title": "Nicotine Addiction -- Enhancing Healthcare Team Outcomes -- Outcomes", "content": "Nicotine addiction affects millions of people all over the globe and has a very high morbidity and mortality. Besides causing cancers, increasing the risk of adverse cardiac events and stroke, it also results in premature birth, spontaneous abortions and peripheral vascular disease. The costs to healthcare from the adverse health affects as a result of nicotine are enormous. Stopping nicotine addiction is another industry that has evolved over the past decade with very poor success rates. Most nicotine addicts cease smoking more to good luck rather than any bona fide remedy. All healthcare workers should try and educate the patients on the harm of nicotine; until then the healthcare costs will continue to increase. [19] [20] [21] [Level 5]", "contents": "Nicotine Addiction -- Enhancing Healthcare Team Outcomes -- Outcomes. Nicotine addiction affects millions of people all over the globe and has a very high morbidity and mortality. Besides causing cancers, increasing the risk of adverse cardiac events and stroke, it also results in premature birth, spontaneous abortions and peripheral vascular disease. The costs to healthcare from the adverse health affects as a result of nicotine are enormous. Stopping nicotine addiction is another industry that has evolved over the past decade with very poor success rates. Most nicotine addicts cease smoking more to good luck rather than any bona fide remedy. All healthcare workers should try and educate the patients on the harm of nicotine; until then the healthcare costs will continue to increase. [19] [20] [21] [Level 5]"}
{"id": "article-25879_26", "title": "Nicotine Addiction -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Nicotine Addiction -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}